Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frieder Kees

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|January 26, 2026
Protein binding of vancomycin in a large mixed patient population at a university hospitalAlexander Dejaco, Constantin Lier, Sabrina Krautbauer, et al.
International Wound Journal|January 4, 2019
Can systemically administered antibiotics be detected in wound tissues and surfaces under negative pressure wound therapy?Elias Polykandriotis, Raymund E Horch, Matthias Jost, et al.
Therapeutic Drug Monitoring|June 17, 2006
Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteersFrieder Kees, Michael Bucher, Frank Schweda, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2013
Population pharmacokinetics and pharmacodynamic evaluation of intravenous and enteral moxifloxacin in surgical intensive care unit patientsMartin Georg Kees, André Schaeftlein, Helene Anna Haeberle, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2014
Unbound fraction of ertapenem in intensive care unit patientsUwe Liebchen, Alexander Kratzer, Sebastian G Wicha, et al.
GMS Infectious Diseases|January 24, 2019
Decreased protein binding of moxifloxacin in patients with sepsis?Christoph Dorn, Hartmuth Nowak, Caroline Weidemann, et al.
Annals of the Rheumatic Diseases|December 4, 2013
Anti-inflammatory effects of cell-based therapy with tyrosine hydroxylase-positive catecholaminergic cells in experimental arthritisZsuzsa Jenei-Lanzl, Silvia Capellino, Frieder Kees, et al.
Journal of Clinical Pharmacology|January 21, 2015
Population pharmacokinetics and target attainment analysis of moxifloxacin in patients with diabetic foot infectionsSebastian G Wicha, Thomas Haak, Karl Zink, et al.
International Journal of Antimicrobial Agents|August 15, 2006
Liver tissue concentrations of levofloxacin after single intravenous administration of 500 mg for antibiotic prophylaxis in liver surgeryMalte Weinrich, Stefan Scheingraber, Tatiana Stremovskaia, et al.
Acta Orthopaedica|February 1, 2008
Tissue concentrations of vancomycin and Moxifloxacin in periprosthetic infection in ratsJohannes Beckmann, Frieder Kees, Jens Schaumburger, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|January 26, 2026
Protein binding of vancomycin in a large mixed patient population at a university hospitalAlexander Dejaco, Constantin Lier, Sabrina Krautbauer, et al.
International Wound Journal|January 4, 2019
Can systemically administered antibiotics be detected in wound tissues and surfaces under negative pressure wound therapy?Elias Polykandriotis, Raymund E Horch, Matthias Jost, et al.
Therapeutic Drug Monitoring|June 17, 2006
Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteersFrieder Kees, Michael Bucher, Frank Schweda, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2013
Population pharmacokinetics and pharmacodynamic evaluation of intravenous and enteral moxifloxacin in surgical intensive care unit patientsMartin Georg Kees, André Schaeftlein, Helene Anna Haeberle, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2014
Unbound fraction of ertapenem in intensive care unit patientsUwe Liebchen, Alexander Kratzer, Sebastian G Wicha, et al.
GMS Infectious Diseases|January 24, 2019
Decreased protein binding of moxifloxacin in patients with sepsis?Christoph Dorn, Hartmuth Nowak, Caroline Weidemann, et al.
Annals of the Rheumatic Diseases|December 4, 2013
Anti-inflammatory effects of cell-based therapy with tyrosine hydroxylase-positive catecholaminergic cells in experimental arthritisZsuzsa Jenei-Lanzl, Silvia Capellino, Frieder Kees, et al.
Journal of Clinical Pharmacology|January 21, 2015
Population pharmacokinetics and target attainment analysis of moxifloxacin in patients with diabetic foot infectionsSebastian G Wicha, Thomas Haak, Karl Zink, et al.
International Journal of Antimicrobial Agents|August 15, 2006
Liver tissue concentrations of levofloxacin after single intravenous administration of 500 mg for antibiotic prophylaxis in liver surgeryMalte Weinrich, Stefan Scheingraber, Tatiana Stremovskaia, et al.
Acta Orthopaedica|February 1, 2008
Tissue concentrations of vancomycin and Moxifloxacin in periprosthetic infection in ratsJohannes Beckmann, Frieder Kees, Jens Schaumburger, et al.
Pageof 6